Teva Pharmaceutical Industries | TEVA - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Aspen Pharmacare ZAR 5.62B 789M 2025-12
Cipla INR 10.18B 2.22B 2026-03
Dr.Reddys Laboratories INR 11.2B 4.16B 2026-06
Guangzhou Baiy CNY 12.33B 2.61B 2026-03
Jiangsu Hengrui CNY 40.96B 591.41M 2025-12
Kalbe Farma IDR 4.39T 344.8B 2026-03
Richter Gedeon HUF 135.63B 61.59B 2024-12
Sh Fosun Pharma CNY 13.1B 1.63B 2025-12
Sun Pharmaceuticals INR 97.71B 15.61B 2026-03
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03